New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 28, 2014
06:16 EDTYUM, MCD, SBUXOSI Group CEO says China food scandal 'completely unacceptable'
OSI Group CEO Sheldon Lavin issued a statement about the firm's unit, Husi Shanghai, regarding the latest food scandal in China. Lavin said, "What happened at Husi Shanghai is completely unacceptable. I will not try and defend it or explain it. It was terribly wrong, and I am appalled that it ever happened in the company that I own. On behalf of Husi and OSI, I sincerely apologize to all of our customers in China. We will bear the responsibility of these missteps, and will make sure that they never happen again. That is my personal commitment and that of our organization. For more than 100 years, OSI has provided safe, quality food and is currently operating at the highest standards in 17 countries serving more than 40 countries around the world. So to have this occur at this Shanghai facility violates the tenets of our company and the values we embrace and live. Upon hearing of the Shanghai issue, I immediately sent our best team of global experts from the OSI Group, and more are on their way, to work with the local team to ensure my promise to you today is met. We are very proud of our newest state-of-the-art facility in Henan. It reflects our confidence and commitment in China. We are also pleased that local Chinese authorities have inspected all our other facilities and have found no issues." World-wide brands such as Yum! Brands' (YUM) KFC, McDonald's (MCD) and Starbucks (SBUX) were affected by the food scandal in the country after allegations arose speculating that Husi Shanghai supplied expired meat to the companies. Reference Link
News For MCD;YUM;SBUX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
December 9, 2014
16:20 EDTYUMYum! Brands provides FY15 operating guidance
Subscribe for More Information
16:18 EDTYUMYum! Brands sees FY14 China division SSS negative mid-single digits
The company said, "As previously reported, China Division sales were significantly impacted by adverse publicity in July regarding improper food handling practices by a former supplier. Sales continue to recover, but at a slower pace than expected. We estimate China Division full-year same-store sales will be negative mid-single digits. With this assumption, we now estimate mid-single-digit full-year EPS growth, excluding Special Items." FY14 EPS consensus $3.24.
16:16 EDTYUMYum! Brands sees FY15 EPS growth at least 10%, consensus $3.78
Yum! expects to deliver at least 10% EPS growth in 2015, excluding Special Items.
09:38 EDTMCDActive equity options trading
Subscribe for More Information
December 8, 2014
16:24 EDTMCDOn The Fly: Closing Wrap
Stocks on Wall Street were lower amid another drop in crude oil prices, which tumbled to five-year lows. The market opened slightly lower following weaker than expected data from China and Japan, with nothing of note on the domestic calendar to get buyers involved in the day’s activity. Near noon, the averages gained downside momentum and though the market pared its losses several times, it was never able to gain any steam to pull the indexes back into the green. ECONOMIC EVENTS: In the U.S., no major economic data was released. In Asia, Chinese exports rose 4.7% from a year earlier in November, which missed the consensus estimate for an 8% increase. Chinese imports fell 6.7% from the prior year last month, compared with projections for a 3.8% increase. Additionally, Japan's revised third quarter gross domestic product estimate showed the economy shrank more than initially thought, with growth contracting an annualized 1.9%. COMPANY NEWS: Shares of Cubist Pharmaceuticals (CBST) surged $26.24, or 35.29%, to $100.60 after Merck (MRK) agreed to acquire the maker of next-generation antibiotics for $102 per share in cash, or $8.4B and the assumption of $1.1B in debt. A number of other antibiotic makers also climbed, including Tetraphase (TTPH), which rose $2.45, or 8.82%, to $30.24, and Cempra (CEMP), which advanced $1.64, or 11.37%, to $16.06, while shares of Merck finished fractionally higher, adding 39c, or 0.63%, to $61.88 following the deal announcement. MAJOR MOVERS: Among the notable gainers following their presentations at the American Society of Hematology, or ASH, annual meeting were Calithera Biosciences (CALA), which gained $2.38, or 22.52%, to $12.95, and Acceleron Pharma (XLRN), which jumped $5.11, or 13.6%, to $42.67. Among the noteworthy losers was McDonald's (MCD), which fell $3.70, or 3.84%, to $92.61 after the Dow member reported a 2.2% decline in global same-restaurant sales in November. Additionally, the fast-food giant warned that its fourth quarter results would be hurt by its sales pressures, supplier issues in China and a stronger U.S. dollar. Also lower were shares of Liquidity Services (LQDT), which plunged $2.77, or 27.0%, to $7.49 after the company disclosed that Wal-Mart (WMT) had terminated a deal to provide it with surplus merchandise. INDEXES: The Dow fell 106.31, or 0.59%, to 17,852.48, the Nasdaq dropped 40.06, or 0.84%, to 4,740.69, and the S&P 500 slipped 15.06, or 0.73%, to 2,060.31.
12:40 EDTMCDOn The Fly: Midday Wrap
Subscribe for More Information
10:08 EDTMCDMcDonald's falls on weak November sales, levels to watch
Subscribe for More Information
09:48 EDTMCDMarket begins lower, averages turns mixed in early trade
Stock futures trade below fair value throughout the pre-market trading session, leading to a lower open for the broader market. The Dow finished last week at an all-time high and just slightly below its next milestone level of 18,000, but it continues to be weighed on during early trading from McDonald's (MCD), which is down over 3% following its November sales report. In early trading, the Dow is down 17 points, the Nasdaq is up 7 points and the S&P is down 1 point.
09:38 EDTMCDMcDonald's sees Q4 margins 'significantly pressured' by top-line performance
Subscribe for More Information
09:20 EDTMCDOn The Fly: Pre-market Movers
Subscribe for More Information
09:13 EDTYUMYum! Brands to host analyst and investor meeting
Subscribe for More Information
07:59 EDTMCDMcDonald's reports November global comparable sales decreased 2.2%
Subscribe for More Information
07:52 EDTSBUXStarbucks price target raised to $97 from $88 at Jefferies
Subscribe for More Information
06:47 EDTSBUXStarbucks coverage resumed with a Conviction Buy at Goldman
Subscribe for More Information
06:46 EDTYUMYum! Brands coverage resumed with a Sell at Goldman
Subscribe for More Information
06:42 EDTMCDMcDonald's coverage resumed with a Neutral at Goldman
Subscribe for More Information
December 5, 2014
16:52 EDTSBUXDow just below 18K as market finishes week with gains
Subscribe for More Information
12:13 EDTSBUXStarbucks hits 52-week high after analysts applaud five-year plan
Shares of Starbucks (SBUX) are climbing after a number of analysts were upbeat about the company's long-term guidance, which it announced yesterday. WHAT'S NEW: After Starbucks yesterday estimated that its revenue would approach $30B in fiscal 2019, up from $16B in fiscal 2014, research firm Piper Jaffray analyst Nicole Regan wrote in a note to investors today that the stock could more than double within four years. The depth and breadth of the plan that Starbucks unveiled yesterday in conjunction with its guidance is "particularly impressive," she contended. Regan was upbeat about the company's plans to double its U.S. food business, launch new technology initiatives, and significantly grow its store count. Following Starbucks' update, the analyst has increased confidence about its ability to generate continued top-line momentum. Regan now believes her previous forecast for the stock to double within five years could be conservative. The analyst reiterated a $100 price target and Overweight rating on the shares. Meanwhile, JPMorgan analyst John Ivankoe was impressed by the company's store expansion plans, sales driving initiatives, and margin enhancing measures, he wrote in a note to investors today. The company looks poised to increase its profits 15%-20% through 2016, and arguably through 2019 as well, Ivankoe stated. Starbucks is a classic, long-term core growth stock, added the analyst, who raised his price target on the name to $89 from $82 and kept an Overweight rating on the shares. PRICE ACTION: In early afternoon trading, Starbucks gained nearly 3% to $83.58. Earlier, the stock set a new 52-week high of $83.92.
07:32 EDTSBUXStarbucks price target raised to $89 from $82 at JPMorgan
Subscribe for More Information
06:53 EDTSBUXPiper sees Starbucks shares doubling within four years
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use